EPCAM Gene Colorectal Cancer Hereditary Nonpolyposis Type 8 Genetic Test
Overview
The EPCAM gene is a gene that provides instructions for making a protein called epithelial cell adhesion molecule. This protein is found on the surface of cells and is involved in cell-to-cell adhesion, which is important for maintaining the structure and function of tissues.
Colorectal cancer, hereditary nonpolyposis type 8 (HNPCC8) is a hereditary condition characterized by an increased risk of developing colorectal cancer and other types of cancer, such as endometrial cancer. HNPCC8 is caused by mutations in the EPCAM gene.
Genetic Test Details
- Test Name: EPCAM Gene Colorectal cancer hereditary nonpolyposis type 8 Genetic Test
- Components: NGS Technology
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Test Type: Cancer
- Doctor: Oncologist
- Test Department: Genetics
- Pre Test Information: Clinical History of Patient who is going for EPCAM Gene Colorectal cancer, hereditary nonpolyposis type 8 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with EPCAM Gene Colorectal cancer, hereditary nonpolyposis type 8 NGS Genetic DNA Test gene EPCAM
Importance of Genetic Testing
NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of colorectal cancer, HNPCC8 NGS genetic testing would involve sequencing the EPCAM gene to identify any mutations or genetic variants that may be associated with an increased risk of developing colorectal cancer.
By identifying mutations in the EPCAM gene, NGS genetic testing can help diagnose individuals with HNPCC8 and guide appropriate management and surveillance strategies for early detection and prevention of colorectal cancer. It can also be used to determine if other family members are at risk of inheriting the mutation and developing cancer.
Conclusion
The EPCAM Gene Colorectal cancer hereditary nonpolyposis type 8 Genetic Test offered by DNA Labs UAE is a valuable tool for identifying individuals at risk of developing colorectal cancer and other associated cancers. With its advanced NGS technology, this genetic test provides accurate and reliable results to aid in diagnosis, management, and prevention of HNPCC8. Consult with an oncologist and undergo a genetic counseling session to understand the significance of this test and its implications for you and your family members.
Test Name | EPCAM Gene Colorectal cancer hereditary nonpolyposis type 8 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Cancer |
Doctor | Oncologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for EPCAM Gene Colorectal cancer, hereditary nonpolyposis type 8 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with EPCAM Gene Colorectal cancer, hereditary nonpolyposis type 8 NGS Genetic DNA Test gene EPCAM |
Test Details |
The EPCAM gene is a gene that provides instructions for making a protein called epithelial cell adhesion molecule. This protein is found on the surface of cells and is involved in cell-to-cell adhesion, which is important for maintaining the structure and function of tissues. Colorectal cancer, hereditary nonpolyposis type 8 (HNPCC8) is a hereditary condition characterized by an increased risk of developing colorectal cancer and other types of cancer, such as endometrial cancer. HNPCC8 is caused by mutations in the EPCAM gene. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of colorectal cancer, HNPCC8 NGS genetic testing would involve sequencing the EPCAM gene to identify any mutations or genetic variants that may be associated with an increased risk of developing colorectal cancer. By identifying mutations in the EPCAM gene, NGS genetic testing can help diagnose individuals with HNPCC8 and guide appropriate management and surveillance strategies for early detection and prevention of colorectal cancer. It can also be used to determine if other family members are at risk of inheriting the mutation and developing cancer. |